KI-Beratung Beta

Produktbild: Managing Multidrug Resistance in Cancer
Vorbesteller Neu

Managing Multidrug Resistance in Cancer Emerging Mechanisms and Plant-based Strategies

172,99 €

inkl. gesetzl. MwSt., Versandkostenfrei


Beschreibung

Plant-derived compounds and nanotechnology converge to combat drug-resistant cancers

Over 90% of cancer deaths in metastatic cases are linked to drug resistance, yet few references integrate phytochemical therapeutics with nanotechnology-based delivery. Managing Multidrug Resistance in Cancer: Emerging...

Beschreibung

Plant-derived compounds and nanotechnology converge to combat drug-resistant cancers

Over 90% of cancer deaths in metastatic cases are linked to drug resistance, yet few references integrate phytochemical therapeutics with nanotechnology-based delivery. Managing Multidrug Resistance in Cancer: Emerging Mechanisms and Plant-based Strategies assembles expert contributors who critically evaluate preclinical and clinical evidence on plant-derived molecules that inhibit efflux pumps, restore apoptosis, and reverse resistance in breast, lung, colorectal, ovarian, and hematologic malignancies.

Contributors detail nanotechnology-based biodegradable delivery systems that enhance selectivity, bioavailability, and retention time while reducing toxicity. The volume covers AI and machine-learning tools for diagnostic improvement, personalized medicine frameworks, and clinical trial data on phytochemical efficacy. Global MDR cancer scenarios in both developed and developing nations receive dedicated analysis, addressing accessibility and economic feasibility of plant-derived treatments.

Key topics also include:

  • Mechanisms of intrinsic and acquired resistance to tamoxifen, EGFR-TKIs, and platinum-based chemotherapeutics across common cancer types
  • Structural diversity and multi-target action of phytochemicals that distinguish them from single-target synthetic agents in MDR reversal
  • Nanocarrier design principles for enhancing solubility, tumor targeting, and controlled release of plant-derived anticancer compounds
  • Translational pathways from preclinical phytochemical research to clinical application, including current trial methodologies and outcomes
  • Toxicity reduction strategies that integrate natural compounds into advanced therapeutic platforms for improved patient survival rates

Designed for researchers and clinicians at the intersection of oncology, pharmacology, and nanotechnology, this volume serves cancer scientists, pharmacognosy specialists, and biomedical professionals seeking low-toxicity treatment approaches. Pharmaceutical developers exploring translational applications of phytochemicals and nanocarriers in precision oncology will find targeted, evidence-based guidance throughout.

Portrait

Vipendra Kumar Singh is a Molecular Oncologist & Postdoctoral Scientist in the Department of Biochemistry, School of Medicines and Health Sciences, George Washington University. His research spans hormone-dependent cancers, network pharmacology, in-silico biology, drug discovery, and molecular biology. He has co-edited two books on related topics in cancer therapeutics and plant-derived compounds.

Ankit Kumar Singh is an Assistant Professor at the University Department of Botany, Lalit Narayan Mithila University. His research focuses on cancer biology, phycology, and nano-biotechnology. He has published more than 20 papers in reputed international journals and edited three books.

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

21.02.2027

Herausgeber Vipendra Kumar Singh + weitere
Verlag John Wiley & Sons Inc

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

21.02.2027

Herausgeber
Verlag John Wiley & Sons Inc
Seitenzahl

624

Auflage

1. Auflage

Sprache

Englisch

ISBN

978-1-394-42328-6

Herstelleradresse

Libri GmbH
Europaallee 1
36244 Bad Hersfeld
DE

Email: gpsr@libri.de

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)

  • Produktbild: Managing Multidrug Resistance in Cancer